The Norway-based company says it completed the initial electromagnetic compatibility (EMC) testing of electronics developed for its next-generation CGM implant. EMC testing ensures that the implant can operate reliably when surrounded by mobile phones, Wi-Fi and other wireless technologies without interference or failure.

Results from the first round confirmed a stable technical foundation for the implant system. The company said in a LinkedIn post that it sets the company up to complete the final touches as it works toward CE mark approval. Lifecare expects full verification within three months with its final optimizations already underway.